VOYAGEUR PHARMACEUTICALS LTD (VM.CA) Stock Income Statement
TSX-V:VM - CA92918C1014 - Common Stock
0.165 CAD
0 (0%)
| TTM (2025-5-31) | 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | 411.84K | 319.47K | |||
| Gross Profit | N/A | N/A | N/A | -411.84K | -319.47K | |||
| Operating Expenses | 2.17M | 1.70M | 1.35M | 1.75M | 2.05M | |||
| Research and Development | N/A | N/A | N/A | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 2.17M | 1.70M | 1.34M | 1.75M | 2.05M | |||
| Operating Income | -2.17M | -1.70M | -1.35M | -1.75M | -2.05M | |||
| Interest Income/Expense | N/A | 0.00 | -4.50K | N/A | N/A | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | -7.90K | -48.60K | -2.00K | 0.00 | |||
| Income Before Taxes | -2.18M | -1.71M | -1.40M | -1.75M | -2.05M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -2.18M | -1.71M | -1.40M | -1.75M | -2.05M | |||
| EBITDA | -2.17M | -1.70M | -1.34M | -1.75M | -2.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | |||
| Statistics | ||||||||
All data in CAD